Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function.

Por Mushlin, P. S., Cusack, B. J., Boucek, R. J., Andrejuk, T., Li, X., Olson, R. D.
Publicado em 1993

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.

Por Olson, R D, Mushlin, P S, Brenner, D E, Fleischer, S, Cusack, B J, Chang, B K, Boucek, R J
Publicado em 1988